NeuroSense Therapeutics (NRSN) Other Accumulated Expenses (2020 - 2026)
NeuroSense Therapeutics' Other Accumulated Expenses came in at $2.27 million for Q2 2026, up 104.5% from $1.11 million a year earlier.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, NeuroSense Therapeutics' Other Accumulated Expenses was $1.72 million, up 106.4% from FY2024.
- Other Accumulated Expenses carries a five-year compound annual growth rate of 92.5% (FY2020 to FY2025).
- Going back by year, Other Accumulated Expenses was $832,000 in FY2024 (-58.4%), $2 million in FY2023 (+62.9%), $1.23 million in FY2022 (+120.1%) and $558,000 in FY2021 (+758.5%).
- The Q2 2026 figure represents the highest quarterly Other Accumulated Expenses since Q3 2024.
- Year-over-year, Other Accumulated Expenses increased in three of the last five quarters, with growth averaging 26.7%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q4 2021 (growth of 758.5%), and the weakest in Q4 2024 (a decline of 58.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | NeuroSense Therapeutics | 4.00 Mn | -436,466.80 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.27 Mn |
| Dec 31, 2025 | 1.72 Mn |
| Jun 30, 2025 | 1.11 Mn |
| Dec 31, 2024 | 832,000.00 |
| Sep 30, 2024 | 2.39 Mn |
| Jun 30, 2024 | 2.03 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | 1.90 Mn |
| Jun 30, 2023 | 1.92 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2022 | 1.23 Mn |
| Sep 30, 2022 | 605,000.00 |
| Jun 30, 2022 | 616,000.00 |
| Mar 31, 2022 | 1.05 Mn |
| Dec 31, 2021 | 558,000.00 |
| Dec 31, 2020 | 65,000.00 |
API Access
NeuroSense Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();